| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8541 |
| Human Intestinal Absorption | HIA+ | 0.9853 |
| Caco-2 Permeability | Caco2+ | 0.6888 |
| P-glycoprotein Substrate | Non-substrate | 0.6471 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8543 |
| Non-inhibitor | 0.9269 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8836 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9327 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7716 |
| CYP450 2D6 Substrate | Non-substrate | 0.8878 |
| CYP450 3A4 Substrate | Non-substrate | 0.5601 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8445 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8815 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9619 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9856 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9381 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8092 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9598 |
| Non-inhibitor | 0.8615 |
| AMES Toxicity | Non AMES toxic | 0.9635 |
| Carcinogens | Non-carcinogens | 0.8161 |
| Fish Toxicity | High FHMT | 0.8507 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9990 |
| Honey Bee Toxicity | High HBT | 0.5740 |
| Biodegradation | Not ready biodegradable | 0.7807 |
| Acute Oral Toxicity | III | 0.8444 |
| Carcinogenicity (Three-class) | Non-required | 0.6938 |